Not long ago, chronic obstructive pulmonary disease (COPD) was considered a Cinderella,
an unappealing disease lacking therapeutic options. It was also stigmatised as a …

Inhaled corticosteroids (ICS) are commonly prescribed to COPD patients, particularly those
with more advanced stages of the disease. These patients are also at increased risk of lung …

Lung cancer is one of the leading causes of mortality in patients with COPD. Beyond the
common risk factors, COPD and lung cancer are closely related, sharing linked pathogenic …

Chronic obstructive pulmonary disease (COPD) is a major cause of mortality and morbidity
worldwide with an estimated 2.75 million deaths in 2000 (fourth leading cause of death). The …

Background There has been debate on whether inhaled corticosteroids (ICS) reduce the
incidence of lung cancer amongst patients with Chronic Obstructive Lung Disease (COPD) …

Background Inhaled corticosteroids (ICS) are suggested for potential chemoprevention of
lung cancer. Several observational studies in patients with chronic obstructive pulmonary …

Inhaled corticosteroids (ICSs) are often prescribed in patients with chronic obstructive
pulmonary disease (COPD). Their impact on the risk of lung cancer, a leading cause of …

Background It remains uncertain whether there is a protective effect of inhaled
corticosteroids (ICs) against lung cancer in chronic obstructive pulmonary disease (COPD) …

RATIONALE AND OBJECTIVES: COPD is associated with an increased risk of lung cancer.
We examined whether inhaled corticosteroids (ICS) used concomitantly with long-acting …

The new Global Initiative for Chronic Obstructive Lung Disease (GOLD) report on the
prevention, diagnosis and management of COPD advises using inhaled steroids less …